The efficacy, safety, and tolerability of ivermectin compared with current topical treatments for the inflammatory lesions of rosacea: a network meta-analysis.

Springerplus · 2016 · PMC4956638 · PMID 27504249

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

When comparing ivermectin 1 % cream QD with azelaic acid 15 % gel QD the difference between treatments did not reach statistical significance in the RR analysis, although the NNT was lower with ivermectin 1 % cream QD compared with azelaic acid 15 % gel QD (3 vs. 7).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.